Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal grantsHow to Find Grants for Nonprofits
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to apply for a grantGrant Applications vs. RFPs: Writing Differences Explained
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›Research on Current Topics in Alzheimer's Disease and Its…

U.S. National Institutes of Health·United States of America

Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Optional)

Closes 11/20/2025$100k – $500kGrants Notice
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The purpose of this Notice of Funding Opportunity (NOFO) is to invite applications proposing new tests, animal models, techniques, etc. to advance research on Alzheimer's disease (AD) and its related dementias (ADRD) that need additional preliminary data with broader dissemination to establish them for more general use in this research field. The priority topics will be announced through a series of Notices published subsequent to this NOFO. • Eligible applicants include private institutions of higher education, state governments, special district governments, public and state-controlled institutions of higher education, nonprofits, and others. • The application submission deadline is November 16, 2027. • The opportunity is sponsored by the National Institutes of Health (NIH). • The funding instrument for this opportunity is a grant. • The research should focus on current topics in Alzheimer's disease and its related dementias.

Attached files

Contact

[email protected]

(301) 402-2541

Key dates

Opened
12/30/2024
Closes
11/20/2025

Last updated

Details

Type
Grants Notice
Industry
Healthcare and Medical Services
NAICS
541710
Solicitation №
PAR-25-331

Budget estimate

$100,000 – $500,000

The budget amount for this grant is not explicitly stated, but based on the information provided, it can be estimated that the grant amount will be in the range of $100,000 to $500,000. This estimation is based on the fact that the funding instrument is a grant and the research focus is on a specific area of Alzheimer's disease and related dementias. The actual budget amount may vary depending on the specific proposal and the NIH's funding priorities.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 80%

NIA Expanding Research in AD/ADRD (ERA) Postbaccalaureate Research Education Program (R25 Independent Clinical Trial Not Allowed)

Closes 5/26/2027Opened 6/9/2025

U.S. National Institutes of Health·United States of America

79% match

Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)

Closes 6/17/2027Opened 8/13/2026

U.S. National Institutes of Health·United States of America

79% match

Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)

Closes 11/5/2027Opened 11/15/2021

U.S. National Institutes of Health·United States of America

78% match

Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed)

Closes 5/7/2028Opened 12/30/2024

U.S. National Institutes of Health·United States of America

78% match

Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional)

Closes 11/9/2026Opened 2/12/2026

U.S. National Institutes of Health·United States of America

78% match

New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional)

Closes 5/7/2027Opened 3/19/2024

U.S. National Institutes of Health·United States of America

77% match

NIA Expanding Research in AD/ADRD (ERA) Summer Research Education Program (R25 Independent Clinical Trial Not Allowed)

Closes 5/26/2027Opened 6/9/2025

U.S. Department Of Defense·Maryland

76% match

RFI Alzheimer’s Research Program (AZRP) Public

Closes 12/4/2026Opened 10/27/2026

U.S. National Institutes of Health·United States of America

75% match

Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)

Closes 6/16/2028Opened 3/16/2026

U.S. National Institutes of Health·United States of America

75% match

Functional Target Validation for Alzheimer's Disease-Related Dementias

Closes 11/5/2026Opened 3/11/2026

U.S. National Institutes of Health·United States of America

75% match

Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)

Closes 7/20/2028Opened 6/9/2025

U.S. National Institutes of Health·United States of America

75% match

Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)

Closes 12/3/2027Opened 12/5/2024

U.S. National Institutes of Health·United States of America

75% match

New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Optional)

Closes 5/7/2027Opened 3/19/2024

U.S. National Institutes of Health·United States of America

74% match

Palliative Care Research Across the Lifespan: Leveraging the Palliative Care Consortium (R01 Clinical Trial Optional)

Closes 11/5/2029Opened 9/29/2025

U.S. National Institutes of Health·United States of America

74% match

Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)

Closes 11/19/2026Opened 8/23/2023

U.S. National Institutes of Health·United States of America

74% match

Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)

Closes 8/11/2027Opened 12/30/2024

U.S. National Institutes of Health·United States of America

74% match

Mechanism for Time-Sensitive Substance Use Research (R21 Clinical Trial Optional)

Closes 9/9/2027Opened 9/20/2024

U.S. National Institutes of Health·United States of America

74% match

NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required)

Closes 1/7/2028Opened 12/18/2024

U.S. National Institutes of Health·United States of America

74% match

NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Not Allowed)

Closes 1/7/2028Opened 12/18/2024

U.S. National Institutes of Health·United States of America

74% match

NIA Academic Leadership Career Award (K07 Independent Clinical Trial Not Allowed)

Closes 11/12/2027Opened 11/6/2024

U.S. National Institutes of Health·United States of America

73% match

Early-Stage Dissemination and Implementation Research in Communication Disorders (R21 Clinical Trial Optional)

Closes 6/17/2027Opened 6/6/2025

U.S. National Institutes of Health·United States of America

73% match

Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)

Closes 11/18/2026Opened 10/30/2023

U.S. National Institutes of Health·United States of America

73% match

Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)

Closes 9/7/2028Opened 11/12/2024

U.S. Administration for Community Living·United States of America

73% match

Alheimer's Disease Programs Initiative (ADPI) - State Programs for Dementia Specific Respite

Closes 7/29/2034Opened 10/19/2026

U.S. National Institutes of Health·United States of America

73% match

Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)

Closes 11/10/2026Opened 8/28/2025